Cancer continues to be a leading cause of morbidity and mortality worldwide. Molecular imaging has emerged as a groundbreaking approach in the battle against cancer, providing valuable information for early detection, accurate staging, and monitoring treatment responses. PET imaging with radiotracers targeting specific molecules, such as glucose analogs (FDG), has revolutionized cancer diagnosis. By detecting increased glucose metabolism in tumors, PET scans can identify primary cancers and ... Read more
